查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1372767

血糖監測設備市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品類型、按應用、最終用戶、地區和競爭細分

Blood Glucose Monitoring Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 174 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年，全球血糖監測設備市場估值達到 177.9 億美元，預計在預測期內將出現顯著成長，預計到 2028 年年複合成長率 (CAGR) 為 7.03%。對於糖尿病患者來說至關重要的過程，包括定期檢測血糖值。它在將血糖水平維持在目標範圍內發揮關鍵作用，並為有效的糖尿病管理提供了寶貴的見解。這包括監測治療進展、評估藥物對血糖水平的影響以及全面了解病情如何影響血糖水平。

市面上有多種血糖監測設備，俗稱血糖儀。這些設備專為滿足不同類型的糖尿病而量身定做，包括 1 型、2 型和妊娠糖尿病。血糖監測設備市場的成長可歸因於幾個關鍵因素，包括糖尿病盛行率不斷上升、監測和診斷工具的技術進步、早期糖尿病檢測以及對連續血糖監測設備不斷成長的需求。

血糖儀是一種緊湊型電子設備，專門設計用於分析使用刺血針和採血裝置透過小刺獲得的血液樣本。隨後，將血液樣本放置在拋棄式測試條上，然後將其插入儀表中。血糖儀透過試紙與血液之間的電化學反應來讀取血液中的葡萄糖水平。這些儀表採用電池供電，結構緊湊，可以舒適地握在手掌中。血液樣本流經設備內的管道，準確測定葡萄糖濃度，促進高效率且使用者友善的血糖監測。

市場概況
預測期 2024-2028
2022 年市場規模 177.9億美元
2028 年市場規模 265.2億美元
2023-2028 年年複合成長率 7.03%
成長最快的細分市場 連續血糖監測
最大的市場 北美洲

主要市場促進因素

糖尿病盛行率高

糖尿病是一種慢性疾病，當胰臟無法產生足夠的胰島素或無法有效地利用它來調節體內血糖水平時，就會發生糖尿病。如果管理不當，血糖控制失衡可能會導致各種併發症和健康風險。

老年人口增加

預計老年人口的增加將對血糖監測設備的需求產生重大影響。隨著全球人口老化，糖尿病（尤其是第 2 型糖尿病）的盛行率正在上升。罹患糖尿病的風險隨著年齡的成長而增加。由於胰島素敏感性降低和缺乏身體活動等因素，老年人更容易患第 2 型糖尿病。因此，越來越多的老年人需要定期監測血糖水平。

醫療保健的進步導致壽命延長，但隨著壽命的延長，糖尿病等慢性病的風險也會增加。老年人的壽命越來越長，許多人需要持續的糖尿病管理，需要定期監測血糖。預防保健措施對於控制老年人糖尿病至關重要。定期監測可以及早發現異常的血糖水平，使醫療保健提供者能夠及時進行干涉，改變生活方式或調整藥物。糖尿病是一個全球性的健康問題，影響各個年齡層的人。隨著全球糖尿病盛行率持續成長，老年人口仍然是受影響人群的很大一部分，這增加了全球對血糖監測設備的需求。

肥胖率的成長

肥胖症的日益普及預計將對血糖監測設備的需求產生重大影響。肥胖是第 2 型糖尿病發展的一個公認的危險因素，這種疾病的特徵是胰島素功能受損和血糖水平升高。肥胖與第2型糖尿病的發生有密切相關。體內過多的脂肪，特別是腹部周圍的脂肪，會導致胰島素阻抗，即身體細胞對胰島素無法有效反應。這種胰島素抗性通常會發展為糖尿病，需要定期監測血糖來控制病情。監測血糖水平對於早期發現具有肥胖相關危險因子的個體的糖尿病至關重要。定期監測使醫療保健提供者能夠及時干涉生活方式改變或藥物治療，以有效預防或管理糖尿病。

肥胖管理通常涉及生活方式的改變，例如飲食改變和增加體力活動。血糖監測設備為個人提供即時回饋，了解他們的選擇如何影響他們的血糖水平，從而激發更健康的行為。血糖監測設備變得更加方便用戶使用和易於使用，使肥胖和糖尿病患者能夠積極參與他們的醫療保健。這些設備使患者能夠對其日常生活和藥物管理做出明智的決定。

技術進步

技術進步有望徹底改變血糖監測領域，從而顯著增加對這些設備的需求。這些創新提高了血糖監測儀的準確性、便利性和連接性，使其更加方便用戶使用和有效。 CGM 系統的開發可以即時監測血糖值。這些穿戴式裝置提供連續資料，使糖尿病患者和醫療保健提供者能夠立即做出治療決定。由於 CGM 設備能夠改善血糖控制並降低低血糖和高血糖風險，因此對 CGM 設備的需求不斷增加。

研究人員在開發非侵入式血糖監測技術（例如光學感測器和智慧隱形眼鏡）方面取得了重大進展。這些方法消除了指尖採血測試的需要，並提供了更舒適的監測選項，這可以提高患者的依從性和需求。人工智慧和機器學習演算法正在應用於血糖資料分析。這些技術可以預測血糖趨勢、檢測模式並提供個人化見解，使糖尿病患者能夠主動做出有關其健康的決策。

主要市場挑戰

監測設備的高成本和複雜性

血糖監測設備雖然可以有效管理糖尿病，但也可能帶來一定的挑戰。首先，該設備的成本對某些人來說可能是一個障礙，使得最需要它的人無法使用它。此外，監測血糖值的過程可能會很痛苦，給患者帶來不適。另一個問題是結果的準確性，因為糖尿病照護設備可能不會總是提供可靠的讀數。此外，與糖尿病相關的費用的保險範圍通常有限，導致許多醫院和醫療中心無法完全支持患者管理病情。缺乏承保或承保資格已成為醫療保健行業日益嚴重的問題。這些因素共同構成了血糖監測設備市場成長的障礙。

此外，這些設備的使用還存在一些併發症，進一步阻礙了市場的成長。破壞性警報和遺失訊號可能會導致資料缺口，從而難以準確解讀血糖讀數。此外，有些患者可能會因長時間使用該設備而出現皮膚刺激或沾黏問題。這些複雜情況增加了市場面臨的整體障礙。

嚴格的規範架構

血糖監測 (BGM) 設備市場的成長正受到強大監管框架的挑戰。由於美國 FDA 和歐盟歐洲藥品管理局 (EMA) 等監管機構對血糖儀等醫療器材實施嚴格監管，該市場面臨重大障礙。這些法規需要進行廣泛的臨床試驗和研究，以確保產品的安全性和有效性，導致耗時且昂貴的過程，可能會延遲新產品的上市。

對於製造商來說，遵守血糖儀準確性和可靠性的嚴格準則是一項艱鉅且資源密集的任務。此外，監管變化可能會對市場產生不利影響。嚴格的監管框架給市場帶來了重大挑戰，影響創新，增加成本，並導致新產品發布延遲，最終阻礙預測期內的市場成長。

主要市場趨勢

基於智慧手錶的應用程式

基於智慧手錶的應用是影響血糖監測 (BGM) 設備市場成長的重要趨勢。在市場上，越來越傾向於利用基於智慧手錶的應用程式來監測血糖水平。近年來，智慧手錶因其能夠追蹤心率、睡眠模式、身體活動和其他健康指標等各種活動而受到歡迎。這些應用利用連續血糖監測 (CGM) 感測器來測量用戶間質液中的葡萄糖水平。然後收集的資料被傳輸到智慧手錶，使用戶能夠查看他們的血糖水平並監控他們隨時間的進展。

基於智慧手錶的血糖監測應用程式的顯著優勢之一是其便利性和謹慎性。使用者可以監測自己的血糖水平，無需攜帶單獨的設備或刺穿手指來獲取血液樣本。這種便利性使糖尿病患者能夠有效地管理自己的病情並實現最佳的血糖控制。因此，使用者可以採取主動措施來調節血糖水平，例如調整飲食或堅持用藥。隨著穿戴式科技變得更加流行，以及個人在預測期內尋求方便有效的方法來管理自己的健康，基於智慧手錶的血糖監測應用的總體趨勢預計將持續下去。

加強策略發展

加強合作等策略發展在推動市場成長方面發揮關鍵作用。最近的一個例子是羅氏和禮來公司在 2021 年的合作。他們的共同努力重點是加強胰島素筆治療的​​管理，這是糖尿病護理的關鍵方面。此次合作凸顯了羅氏致力於創建一個開放的生態系統，將其解決方案、合作夥伴設備和服務整合到糖尿病的整個連續護理過程中。透過利用這種綜合方法，羅氏不僅可以滿足患者的直接需求，還可以促進醫療保健產業的長期市場成長。

細分市場洞察

產品類型見解

根據產品類型，市場分為兩類：自我監測血糖設備和連續血糖監測設備。其中，連續血糖監測設備領域預計在預測期內將呈現最高的年複合成長率（CAGR）。這種顯著的成長主要歸因於微創手術的日益普及，它為患者提供了更方便、更準確的血糖水平監測方法。隨著連續血糖監測設備領域的發展，預計它將在塑造血糖監測技術的未來方面發揮重要作用。

最終使用者見解

根據最終用戶細分市場，家庭護理細分市場預計將在預測期內顯著成長。推動這一成長的關鍵因素之一是自我監測血糖的革命性方法，它改變了家庭血糖監測方式。自我監測血糖（SMBG）作為短期血糖監測的首選方法在世界各地被廣泛採用。它允許患有或未患有糖尿病的個人在舒適的家中方便地測量血糖水平。這種方法使患者能夠密切監測治療效果，包括飲食、胰島素、運動和壓力管理，從而更好地管理他們的整體健康和福祉。

區域洞察

預計在預測期內，北美將成為全球血糖監測設備市場成長的最大貢獻者。 Technavio 的分析師全面解釋了這段時期塑造市場的區域趨勢和促進因素。

在糖尿病盛行率不斷上升、人們對血糖監測重要性的認知不斷提高以及技術進步導致進一步發展等因素的推動下，該地區的市場預計將呈現穩定成長。該市場的主要參與者包括雅培實驗室、羅氏診斷、LifeScan、Dexcom 等。美國是北美血糖儀的主要銷售市場，其顯著成長主要是由於肥胖和糖尿病盛行率的上升。因此，該地區對血糖監測設備和服務的需求大幅增加。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球血糖監測設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型（自我監測血糖設備和連續血糖監測設備）
    • 按應用（1 型糖尿病、2 型糖尿病、妊娠期糖尿病）
    • 按最終使用者（家庭護理機構、醫院、其他）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章：北美血糖監測設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲血糖監測設備市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區血糖監測設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲血糖監測設備市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲血糖監測設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非血糖監測設備
    • 沙烏地阿拉伯血糖監測設備
    • 阿拉伯聯合大公國血糖監測設備

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球血糖監測設備市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 服務內容
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Roche Holding AG
    • Dexcom Inc.
    • Medtronic PLC
    • Arkray Inc.
    • Ascensia Diabetes Care
    • Agamatrix Inc.
    • Bionime Corporation
    • Acon Laboratories Inc.
    • Medisana AG
    • Rossmax International Ltd

第 16 章：策略建議

關於我們及免責聲明

簡介目錄
Product Code: 7267

In 2022, the Global Blood Glucose Monitoring Devices Market achieved a valuation of USD 17.79 billion, and it is poised for remarkable growth in the forecast period with a projected Compound Annual Growth Rate (CAGR) of 7.03% through 2028. Blood glucose monitoring is a vital process for individuals with diabetes, involving the regular testing of blood sugar levels. It plays a pivotal role in maintaining glucose levels within the target range and provides invaluable insights for effective diabetes management. This includes monitoring treatment progress, assessing the impact of medication on blood sugar levels, and gaining a comprehensive understanding of how the condition influences glucose levels.

A variety of blood glucose monitoring devices, commonly known as blood glucose meters, are available in the market. These devices are tailored to cater to different types of diabetes, encompassing Type 1, Type 2, and gestational diabetes. The growth of the Blood Glucose Monitoring Devices Market can be attributed to several key factors, including the escalating prevalence of diabetes, technological advancements in monitoring and diagnostic tools, early diabetes detection, and the growing demand for continuous glucose monitoring devices.

Blood glucose meters are compact electronic devices specially designed for the analysis of blood samples obtained through a small prick using a lancet and lancing device. Subsequently, the blood sample is placed onto a disposable test strip, which is then inserted into the meter. The meter reads the glucose level in the blood through an electrochemical reaction between the test strip and the blood. These meters are battery-powered and compact enough to fit comfortably in the palm of one's hand. The blood sample flows through a tube within the device, and the glucose concentration is accurately determined, facilitating efficient and user-friendly glucose monitoring.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 17.79 Billion
Market Size 2028USD 26.52 Billion
CAGR 2023-20287.03%
Fastest Growing SegmentContinuous Blood Glucose Monitoring
Largest MarketNorth America

Key Market Drivers

High Prevalence of Diabetes

Diabetes is a chronic disease that occurs when the pancreas does not produce enough insulin or cannot effectively use it to regulate body sugar levels. This imbalance in blood glucose control can lead to various complications and health risks if not managed properly.

According to the International Diabetes Federation, it is estimated that in 2021, there were approximately 537 million people worldwide living with diabetes. This number is projected to increase to 643 million by 2030 and a staggering 783 million by 2045. The significant growth in the diabetic population is primarily attributed to the rising prevalence of sedentary lifestyles, poor dietary habits, and decreased physical activity. It is worth noting that the impact of diabetes is not evenly distributed across the globe. The prevalence of diabetes has risen more rapidly in low- and middle-income countries compared to high-income countries. This disparity can be attributed to various factors, including limited access to healthcare resources, inadequate education about diabetes management, and socioeconomic challenges.

Given these alarming statistics and trends, the demand for blood glucose monitoring devices is expected to surge in the coming years. These devices play a crucial role in helping individuals with diabetes monitor their blood sugar levels and make informed decisions about their treatment plans. They provide a convenient and efficient way to track glucose levels, thereby empowering individuals to manage their condition effectively and improve their overall quality of life. In conclusion, the increasing prevalence of diabetes, particularly in low- and middle-income countries, underscores the urgent need for effective management strategies and access to proper healthcare resources. The use of blood glucose monitoring devices is one of the key tools in managing diabetes and ensuring better health outcomes for individuals living with this chronic condition.

Increasing Geriatric Population

The increasing geriatric population is expected to have a significant impact on the demand for blood glucose monitoring devices. As the global population ages, the prevalence of diabetes, particularly Type 2 diabetes, is on the rise. The risk of developing diabetes increases with age. Elderly individuals are more prone to Type 2 diabetes due to factors like decreased insulin sensitivity and physical inactivity. As a result, a growing number of seniors require regular monitoring of their blood glucose levels.

Advances in healthcare have led to longer lifespans, but with extended longevity often comes an increased risk of chronic conditions like diabetes. Seniors are living longer, and many require ongoing diabetes management, necessitating regular blood glucose monitoring. Preventive healthcare measures are crucial in managing diabetes among the elderly. Regular monitoring allows for early detection of abnormal blood glucose levels, enabling healthcare providers to intervene promptly with lifestyle modifications or medication adjustments. Diabetes is a global health concern, affecting people of all ages. As the worldwide prevalence of diabetes continues to grow, the elderly population remains a substantial portion of those affected, contributing to the demand for blood glucose monitoring devices on a global scale.

Growth in Obesity Rates

The growing prevalence of obesity is anticipated to have a substantial impact on the demand for blood glucose monitoring devices. Obesity is a well-established risk factor for the development of Type 2 diabetes, a condition characterized by impaired insulin function and elevated blood glucose levels. Obesity is closely linked to the development of Type 2 diabetes. Excess body fat, particularly around the abdomen, can lead to insulin resistance, where the body's cells do not respond effectively to insulin. This insulin resistance often progresses to diabetes, necessitating regular blood glucose monitoring to manage the condition. Monitoring blood glucose levels is crucial for the early detection of diabetes in individuals with obesity-related risk factors. Regular monitoring allows healthcare providers to intervene promptly with lifestyle modifications or medications to prevent or manage diabetes effectively.

Obesity management often involves lifestyle modifications, such as dietary changes and increased physical activity. Blood glucose monitoring devices provide individuals with real-time feedback on how their choices impact their blood glucose levels, motivating healthier behaviors. Blood glucose monitoring devices are becoming more user-friendly and accessible, empowering individuals with obesity and diabetes to actively participate in their healthcare. These devices enable patients to make informed decisions about their daily routines and medication management.

Technological Advancements

Technological advancements are poised to revolutionize the field of blood glucose monitoring, significantly boosting the demand for these devices. These innovations are enhancing the accuracy, convenience, and connectivity of blood glucose monitors, making them more user-friendly and effective. The development of CGM systems allows for real-time monitoring of blood glucose levels. These wearable devices provide continuous data, enabling individuals with diabetes and healthcare providers to make immediate treatment decisions. The demand for CGM devices is on the rise due to their ability to improve glycemic control and reduce the risk of hypoglycemia and hyperglycemia.

Researchers are making significant progress in developing non-invasive glucose monitoring technologies, such as optical sensors and smart contact lenses. These approaches eliminate the need for fingerstick tests and offer more comfortable monitoring options, which can lead to increased patient compliance and demand. AI and machine learning algorithms are being applied to blood glucose data analysis. These technologies can predict blood glucose trends, detect patterns, and provide personalized insights, empowering individuals with diabetes to make proactive decisions about their health.

Key Market Challenges

High-Cost Nature and Complications for Monitoring Devices

The glucose monitoring device, while effective in managing diabetes, can pose certain challenges. Firstly, the cost of the device can be a barrier for some individuals, making it inaccessible to those who need it the most. Additionally, the process of monitoring glucose levels can be painful, causing discomfort for patients. Another concern is the accuracy of the results, as diabetes care devices may not always provide reliable readings. Furthermore, insurance coverage for diabetes-related expenses is often limited, leaving many hospitals and healthcare centers unable to fully support patients in managing their condition. This lack of coverage or qualifications for coverage has become a growing issue in the healthcare industry. These factors, together, act as barriers to the growth of the market for glucose monitoring devices.

Moreover, several complications are associated with the use of these devices, further hindering market growth. Disruptive alerts and lost signals can lead to data gaps, making it challenging to accurately interpret glucose readings. Additionally, some patients may experience skin irritation or adhesive issues due to prolonged use of the devices. These complications add to the overall hindrance faced by the market.

Stringent Regulatory Framework

The Blood Glucose Monitoring (BGM) Devices Market growth is being challenged by a robust regulatory framework. The market faces significant hurdles due to stringent regulations imposed by regulatory bodies such as the US FDA and the European Union's European Medicines Agency (EMA) on medical devices, including blood glucose meters. These regulations necessitate extensive clinical trials and studies to ensure product safety and efficacy, leading to time-consuming and expensive processes that can delay new product launches.

Compliance with strict guidelines for accuracy and reliability of blood glucose meters is a demanding and resource-intensive task for manufacturers. Moreover, regulatory changes can have adverse effects on the market. The stringent regulatory framework poses a significant challenge to the market, impacting innovation, increasing costs, and causing delays in new product launches, ultimately impeding market growth during the forecast period.

Key Market Trends

Smart Watch-Based Apps

Smartwatch-based applications are a significant trend that is influencing the growth of the Blood Glucose Monitoring (BGM) Devices Market. Within the market, there is an increasing inclination towards utilizing smartwatch-based applications for monitoring blood glucose levels. In recent years, smartwatches have gained popularity due to their ability to track various activities such as heart rate, sleep patterns, physical activity, and other health metrics. These applications utilize Continuous Glucose Monitoring (CGM) sensors to measure glucose levels in the user's interstitial fluid. The collected data is then transferred to the smartwatch, enabling users to view their glucose levels and monitor their progress over time.

One of the notable advantages of smartwatch-based blood glucose monitoring applications is their convenience and discretion. Users can monitor their glucose levels without the need for carrying a separate device or performing finger pricks to obtain blood samples. This convenience empowers individuals with diabetes to effectively manage their condition and achieve optimal blood sugar control. Consequently, users can take proactive measures to regulate their glucose levels, such as making dietary adjustments or adhering to medication. The overall trend towards smartwatch-based blood glucose monitoring applications is expected to continue as wearable technology becomes more prevalent and individuals seek convenient and effective methods to manage their health during the forecast period.

Increasing Strategic Developments

Increasing strategic developments, such as collaborations, play a pivotal role in driving market growth. A recent example of this is the collaboration between Roche and Eli Lilly and Company in 2021. Their joint efforts are focused on enhancing the management of insulin pen therapy, a critical aspect of diabetes care. This collaboration underscores Roche's commitment to creating an open ecosystem that integrates its solutions, partner devices, and services across the entire continuum of care in diabetes. By leveraging this comprehensive approach, Roche is not only addressing the immediate needs of patients but also facilitating long-term market growth in the healthcare industry.

Segmental Insights

Product Type Insights

Based on the product type, the market is divided into two categories: self-monitoring glucose devices and continuous glucose monitoring devices. Among these, the continuous glucose monitoring devices segment is projected to exhibit the highest compound annual growth rate (CAGR) during the forecast period. This remarkable growth can be primarily attributed to the increasing adoption of minimally invasive procedures, which offer patients a more convenient and accurate way of monitoring their glucose levels. With the continuous glucose monitoring devices segment gaining traction, it is expected to play a significant role in shaping the future of glucose monitoring technology.

End User Insights

Based on the end user segment, the home care segment is projected to experience significant growth during the forecast period. One of the key factors driving this growth is the revolutionary approach of self-monitoring of blood glucose, which has transformed home-based glucose monitoring. Self-monitoring blood glucose (SMBG) is widely adopted worldwide as the preferred method for short-term glucose monitoring. It allows individuals, with or without diabetes, to conveniently measure their blood sugar levels in the comfort of their own homes. This approach empowers patients to closely monitor the effects of their treatment, including diet, insulin, exercise, and stress management, leading to better management of their overall health and well-being.

Regional Insights

North America is projected to be the largest contributor to the growth of the global blood glucose monitoring devices market during the forecast period. Technavio's analysts have comprehensively explained the regional trends and drivers shaping the market in this period.

The market in this region is expected to exhibit steady growth, driven by factors such as the increasing prevalence of diabetes, growing awareness of the significance of blood glucose monitoring, and technological advancements leading to further developments. Key players in this market include Abbott Laboratories, Roche Diagnostics, LifeScan, Dexcom, and others. The United States stands as the leading sales market for blood glucose meters in North America, experiencing significant growth primarily due to the rising prevalence of obesity and diabetes. Consequently, the demand for blood glucose monitoring devices and services in the region has witnessed a substantial increase.

Key Market Players

  • Roche Holding AG
  • Dexcom Inc.
  • Medtronic PLC
  • Arkray Inc.
  • Ascensia Diabetes Care
  • Agamatrix Inc.
  • Bionime Corporation
  • Acon Laboratories Inc.
  • Medisana AG
  • Rossmax International Ltd.

Report Scope:

In this report, the Global Blood Glucose Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Glucose Monitoring Devices Market, By Product Type:

  • Self-Monitoring Glucose Devices
  • Continuous Glucose Monitoring Devices

Blood Glucose Monitoring Devices Market, By Application:

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes

Blood Glucose Monitoring Devices Market, By End User:

  • Home Care Settings
  • Hospital
  • Others

Blood Glucose Monitoring Devices Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Blood Glucose Monitoring Devices Market.

Available Customizations:

  • Global Blood Glucose Monitoring Devices market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Glucose Monitoring Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Self-Monitoring Glucose Devices and Continuous Glucose Monitoring Devices)
      • 5.2.1.1. Self-Monitoring Glucose Devices (Glucometers, Test Strips, Lancets)
      • 5.2.1.2. Continuous Glucose Monitoring Devices (Sensors, Transmitters & receivers, Integrated Insulin Pumps)
    • 5.2.2. By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)
    • 5.2.3. By End User (Home Care Settings, Hospital, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map

6. North America Blood Glucose Monitoring Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood Glucose Monitoring Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Blood Glucose Monitoring Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Blood Glucose Monitoring Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Blood Glucose Monitoring Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Blood Glucose Monitoring Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom Blood Glucose Monitoring Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Italy Blood Glucose Monitoring Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. France Blood Glucose Monitoring Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Blood Glucose Monitoring Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Blood Glucose Monitoring Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Blood Glucose Monitoring Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Blood Glucose Monitoring Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Blood Glucose Monitoring Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Blood Glucose Monitoring Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Blood Glucose Monitoring Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Blood Glucose Monitoring Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Blood Glucose Monitoring Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Blood Glucose Monitoring Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Blood Glucose Monitoring Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Blood Glucose Monitoring Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Blood Glucose Monitoring Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Blood Glucose Monitoring Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Blood Glucose Monitoring Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Blood Glucose Monitoring Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Roche Holding AG
    • 15.5.2. Dexcom Inc.
    • 15.5.3. Medtronic PLC
    • 15.5.4. Arkray Inc.
    • 15.5.5. Ascensia Diabetes Care
    • 15.5.6. Agamatrix Inc.
    • 15.5.7. Bionime Corporation
    • 15.5.8. Acon Laboratories Inc.
    • 15.5.9. Medisana AG
    • 15.5.10. Rossmax International Ltd

16. Strategic Recommendations

About Us & Disclaimer